GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sonendo Inc (OTCPK:SONX) » Definitions » Peter Lynch Fair Value

SONX (Sonendo) Peter Lynch Fair Value : $-1,765.75 (As of Jul. 18, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Sonendo Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Here, as of today, Sonendo's PEG is 1. Sonendo's 5-Year TTM EBITDA Growth Rate is 25. Sonendo's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024 was $-70.63. Therefore, the Peter Lynch Fair Value for today is $-1,765.75.

As of today (2025-07-18), Sonendo's share price is $1.15. Sonendo's Peter Lynch fair value is $-1,765.75. Therefore, Sonendo's Price to Peter Lynch Fair Value Ratio for today is N/A.


The historical rank and industry rank for Sonendo's Peter Lynch Fair Value or its related term are showing as below:



SONX's Price-to-Peter-Lynch-Fair-Value is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.625
* Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Sonendo Peter Lynch Fair Value Historical Data

The historical data trend for Sonendo's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sonendo Peter Lynch Fair Value Chart

Sonendo Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Peter Lynch Fair Value
Get a 7-Day Free Trial - - - - -

Sonendo Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Sonendo's Peter Lynch Fair Value

For the Medical Devices subindustry, Sonendo's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sonendo's Price-to-Peter-Lynch-Fair-Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sonendo's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Sonendo's Price-to-Peter-Lynch-Fair-Value falls into.


;
;

Sonendo Peter Lynch Fair Value Calculation

Sonendo's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* 25 *-70.63
=-1,765.75

Sonendo's EPS without NRI for the trailing twelve months (TTM) uses the latest annual data, which was $-70.63.

* Note that for companies that do not have enough quarterly data to calculate the 5-Year TTM EBITDA Growth Rate, we use the annual data for the calculation.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


Sonendo  (OTCPK:SONX) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 25 instead of 15 in this case.

Sonendo's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=1.15/-1,765.75
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sonendo Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of Sonendo's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Sonendo Business Description

Traded in Other Exchanges
N/A
Address
26061 Merit Circle, Suite 102, Laguna Hills, CA, USA, 92653
Sonendo Inc is a commercial-stage medical technology company focused on saving teeth from tooth decay, the prevalent chronic disease globally. It has developed the GentleWave System, a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company operates in two business segments, Product segment which derives key revenue, and Software. Product segment includes sales of the Company's GentleWave System console and related accessories and instruments. Software segment includes sales of the company's traditional software licenses for practice management software to enable an integrated digital office for endodontists.
Executives
Bjarne Bergheim director, officer: President and CEO C/O SONENDO, INC., 2601 MERIT CIRCLE, SUITE 102, LAGUNA HILLS CA 92653
Roy T Chen officer: Chief Talent Officer C/O SONENDO, INC., 2601 MERIT CIRCLE, SUITE 102, LAGUNA HILLS CA 92653
Olav Bergheim director, 10 percent owner ONE PALMER SQUARE, PRINCETON NJ 08542
Pudipeddi Vamsi Mohan Raj director 2820 ORCHARD PARKWAY, SAN JOSE CA 95134
Michael Patrick Watts officer: Chief Financial Officer C/O SONENDO, INC., 2601 MERIT CIRCLE, SUITE 102, LAGUNA HILLS CA 92653
Michael John Smith officer: Chief Commercial Officer C/O SONENDO, INC., 2601 MERIT CIRCLE, SUITE 102, LAGUNA HILLS CA 92653
Andrew J Kirkpatrick officer: Chief Operating Officer 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
General Atlantic, L.p. director, 10 percent owner 55 EAST 52ND STREET, 33RD FLOOR, NEW YORK NY 10055
Bihl Anthony P Iii director 807 SMITH RIDGE ROAD, NEW CANAAN CT 06840
Mehrezad Khakpour officer: Chief Technology Officer C/O SONENDO, INC., 2601 MERIT CIRCLE, SUITE 102, LAGUNA HILLS CA 92653
Jacqueline Arnold Collins officer: VP, General Counsel C/O SONENDO, INC., 2601 MERIT CIRCLE, SUITE 102, LAGUNA HILLS CA 92653
Carolyn Beaver director 3595 JOHN HOPKINS COURT, SAN DIEGO CA 92121
General Atlantic (soi), L.p. 10 percent owner C/O GENERAL ATLANTIC SERVICE COMPANY, LP, 55 EAST 52ND STREET, 33RD FLOOR, NEW YORK NY 10055
General Atlantic Partners (bermuda) Eu, L.p. 10 percent owner C/O GENERAL ATLANTIC SERVICE COMPANY LP, 55 EAST 52ND STREET, 33RD FLOOR, NEW YORK NY 10055
Gap Coinvestments V, Llc 10 percent owner 55 EAST 52ND STREET, 33RD FLOOR, NEW YORK NY 10055